FDA gives permission to Gentek Life Sciences to manufacture Amphotericin B injection in Wardha

Nagpur, May 15 (UNI) With COVID-19 widespread another life-threatening disease that is seen taking a grip mostly among the recovered patients is Mucormycosis a serious but rare fungal infection.
Citing the rapid request of the life-saving injection needed in treating the patients Genetek Life Sciences facility in Wardha which is currently manufacturing another important medicine Remdesivir injections has received approval from Maharashtra FDA to manufacture Amphotericin B injection for Black Fungus infection (Mucormycosis), informed Office of Union Minister Nitin Gadkari through their tweet.
The production will start in Wardha in 15 days and the injection which usually cost to Rs 7,000 will be available just for Rs 1200.
Right now the cost of an injection is Rs 7000 and about 40-50 injections are being given to a patient due to which people are not getting it easily.
This injection made in Wardha, will be available just for Rs 1200 . Over 20,000 injections per day  will be prepared in Genetic Life Sciences, tweet reads.